Annual research & development funding for infectious diseases, 2022

Global annual funding reported for research and development to address neglected tropical diseases (in blue). These are compared to HIV/AIDS, tuberculosis,malaria, and COVID-19 (in orange). This data is expressed in US dollars, adjusted for inflation.

$4.22 billion$1.35 billion$702.43 million$603.53 million$81.83 million$42.71 million$38.88 million$37.81 million$36.26 million$20.99 million$20.53 million$14.23 million$13.58 million$4.61 million$4.16 million$2.4 million$1.89 million$1.4 million$573,758$486,537$166,682COVID-19HIV/AIDSTuberculosisMalariaDengueChagas diseaseSchistosomiasisLeishmaniasisChikungunyaSnakebite envenomingLymphatic filariasisRiver blindnessLeprosyHookwormTapewormWhipwormScabiesRoundwormBuruli ulcerMycetomaTrachoma
Annual research & development funding for infectious diseases

Interactive visualization requires JavaScript